Back
Verisk Analytics Vs. Viking Therapeutics Industry Stock Comparison
Buy
54
VRSK
Verisk Analytics
Last Price:
264.23
Seasonality Move:
5.29%
Buy
58
VKTX
Viking Therapeutics
Last Price:
61.63
Seasonality Move:
36.82%
Buy
54
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
- The current Verisk Analytics [VRSK] share price is $264.25. The Score for VRSK is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- VRSK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.63. The Score for VKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $264.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.63
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.5 | Sell |
Relative Strength Index (14 RSI): | 38.53 | Sell |
Chaikin Money Flow: | -480077 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (265.71 - 272.51) | Sell |
Bollinger Bands (100): | (256.21 - 275.55) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.12 | Buy |
Relative Strength Index (14 RSI): | 49.26 | Sell |
Chaikin Money Flow: | -1176939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.9 - 66.32) | Sell |
Bollinger Bands (100): | (52.14 - 66.8) | Buy |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 265.01 | Sell |
20-day SMA: | 268.97 | Sell |
50-day SMA: | 269.44 | Sell |
200-day SMA: | 251.08 | Buy |
8-day EMA: | 265.55 | Sell |
20-day EMA: | 267.37 | Sell |
50-day EMA: | 267.78 | Sell |
200-day EMA: | 253.76 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.66 | Sell |
20-day SMA: | 61.87 | Sell |
50-day SMA: | 59.76 | Buy |
200-day SMA: | 53.91 | Buy |
8-day EMA: | 63.35 | Sell |
20-day EMA: | 62.66 | Sell |
50-day EMA: | 60.77 | Buy |
200-day EMA: | 52.02 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.21 per share, an increase this year of $0.81 per share, and an increase next year of $0.71 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Verisk Analytics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |